| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/06/2014 | US20140038969 Dihydropyridone p1 as factor xia inhibitors |
| 02/06/2014 | US20140038964 Imidazole based lxr modulators |
| 02/06/2014 | US20140038963 Multifunctional Radical Quenchers For The Treatment Of Mitochondrial Dysfunction |
| 02/06/2014 | US20140038962 Flavivirus Inhibitors and Methods of Their Use |
| 02/06/2014 | US20140038961 3-ureidoisoquinolin-8-yl derivatives |
| 02/06/2014 | US20140038960 Hetaryl-[1,8]naphthyridine derivatives |
| 02/06/2014 | US20140038958 Cdk8-cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer |
| 02/06/2014 | US20140038956 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc). |
| 02/06/2014 | US20140038952 Substituted Amino-Pyrimidine Derivatives |
| 02/06/2014 | US20140038951 Pde10 inhibitors and related compositions and methods |
| 02/06/2014 | US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/06/2014 | US20140038945 Piperazine pde4 inhibitors and uses thereof |
| 02/06/2014 | US20140038943 Serotonin receptor modulator |
| 02/06/2014 | US20140038942 RORgammaT INHIBITORS |
| 02/06/2014 | US20140038938 Substituted dihydropyrazolones and their use |
| 02/06/2014 | US20140038936 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 02/06/2014 | US20140038922 Wnt protein signalling inhibitors |
| 02/06/2014 | US20140038889 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| 02/06/2014 | US20140038883 Novel azacoumarin derivatives having mdr pump inhibiting activity |
| 02/06/2014 | US20140037754 Aminopyrimidines useful as kinase inhibitors |
| 02/06/2014 | CA2876246A1 Substituted pyrazolone compounds and methods of use |
| 02/05/2014 | EP2692726A1 Anti-viral compounds |
| 02/05/2014 | EP2692725A1 Method for producing phenoxypyridine derivative |
| 02/05/2014 | EP2691387A2 Process for the preparation of anhydrous aripiprazole crystal form ii |
| 02/05/2014 | EP2691386A1 Quinoline derivatives as fungicides |
| 02/05/2014 | EP2691385A1 Improved process for preparation of imatinib and its mesylate salt |
| 02/05/2014 | EP2691384A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases |
| 02/05/2014 | EP2691375A1 Substituted benzimidazoles |
| 02/05/2014 | EP2691373A1 3-ureidoisoquinolin-8-yl derivatives |
| 02/05/2014 | EP2691095A2 Imidazolyl amide compounds and uses related thereto |
| 02/05/2014 | CN103562199A Tripeptides incorporating deuterium as inhibitors of hepatitis c virus |
| 02/05/2014 | CN103562198A Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 02/05/2014 | CN103562197A Solid forms of 3-(5-amino-2methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses |
| 02/05/2014 | CN103562185A Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/05/2014 | CN103554111A Aromatic heterocyclic pyridine derivatives and analogs, and preparation method and application thereof |
| 02/05/2014 | CN103554098A One group of 2-chlorine-3-pyridine formyl compounds |
| 02/05/2014 | CN103554088A Benzodiazepine compound and pharmaceutical composition |
| 02/05/2014 | CN103554087A Dabigatran derivative, as well as preparation method and antithrombus application thereof |
| 02/05/2014 | CN103554086A Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 02/05/2014 | CN103554085A Reaction-type halogen amine antibacterial agent, and synthetic method and application thereof |
| 02/05/2014 | CN103554084A Method for selectively preparing 2-bromo-6-substituent pyridine employing copper catalysis |
| 02/05/2014 | CN103554083A Monocrystal structure of cadmium coordination compound with blue light performance and preparation method thereof |
| 02/05/2014 | CN103554082A Method for synthesizing 3-(4-amido-1-isoindolone-2-group)piperidine-2,6-diketone |
| 02/05/2014 | CN103554081A Preparation method of naratriptan impurity B |
| 02/05/2014 | CN103554042A Triazole compounds that modulate hsp90 activity |
| 02/05/2014 | CN103554006A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 02/05/2014 | CN103551193A N2 substituted 1,2,3-triazole ligand/Cu(I) composite catalyst, as well as synthesis and applications thereof |
| 02/05/2014 | CN102731477B Pyrazoloquinoline compound and derivatives thereof, as well as preparation method and application thereof |
| 02/04/2014 | US8642779 Compositions useful as inhibitors of protein kinases |
| 02/04/2014 | US8642774 Compounds |
| 02/04/2014 | US8642773 P38MAP kinase inhibitor |
| 02/04/2014 | US8642770 Indole derivative |
| 02/04/2014 | US8642769 Peperidine-flavan alkaloid compounds derived from African herb tea kinkeliba as anti-diabetic agents |
| 02/04/2014 | US8642760 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/04/2014 | US8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 02/04/2014 | US8642628 Pyrrole inhibitors of S-nitrosoglutathione reductase |
| 02/04/2014 | US8642626 Ethinyl-pyrazole derivative |
| 02/04/2014 | US8642625 Therapeutic agent or preventive agent for urine collection disorder |
| 02/04/2014 | US8642624 Substituted alkylamine derivatives and methods of use |
| 02/04/2014 | US8642620 Heteroaryl-substituted amides comprising an unsaturated or cyclic linker group, and their use as pharmaceuticals |
| 02/04/2014 | US8642618 Carbostyril derivatives including cilostazol for treating fatty liver |
| 02/04/2014 | US8642615 Methods of using 8-carboxamido-2,6-methano-3-benzazocines |
| 02/04/2014 | US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/04/2014 | US8642610 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/04/2014 | US8642609 Modulators of ATP-binding cassette transporters |
| 02/04/2014 | US8642608 Quinazoline derivatives as VEGF inhibitors |
| 02/04/2014 | US8642601 Inhibitors of JNK |
| 02/04/2014 | US8642597 Pyrazole compounds for controlling invertebrate pests |
| 02/04/2014 | US8642588 Short-acting benzodiazepine salts and their polymorphic forms |
| 02/04/2014 | US8642025 Hepatitis C virus inhibitors |
| 02/04/2014 | CA2753405C Nitrogen-containing bicyclic heteroaryl compounds and methods of use |
| 02/04/2014 | CA2666750C Phenylpropionamide compounds and the use thereof |
| 02/04/2014 | CA2641769C Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(r)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders |
| 02/04/2014 | CA2624450C Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/04/2014 | CA2574002C Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 01/30/2014 | WO2014018866A1 Processes for preparing isoindoline-1,3-dione compounds |
| 01/30/2014 | WO2014017643A1 Difluoromethylene compound |
| 01/30/2014 | WO2014017569A1 Pharmaceutical product for lowering blood ldl |
| 01/30/2014 | WO2014017516A1 Method of producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazole-3-yl]pyridin-2-carbonitrile, and intermediary thereof |
| 01/30/2014 | WO2014017515A1 4-[5-(pyridine-4-yl)-1h-1,2,4-triazole-3-yl]pyridine-2-carbonitrile crystalline polymorph and production method therefor |
| 01/30/2014 | WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017045A1 Compound having acridan ring structure, and organic electroluminescent element |
| 01/30/2014 | WO2014016296A1 Process for preparing substituted indole derivatives |
| 01/30/2014 | WO2014016191A1 N-cyclopropyl-n-piperidinyl-amide derivatives and their use as gpr119 modulators |
| 01/30/2014 | WO2014015936A1 Ligands and their preparation |
| 01/30/2014 | WO2014015754A1 Broussonetine compound, preparation method therefor, and application thereof |
| 01/30/2014 | US20140031554 Process for preparing racemic nicotine |
| 01/30/2014 | US20140031552 Processes for preparing isoindoline-1,3-dione compounds |
| 01/30/2014 | US20140031547 CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES |
| 01/30/2014 | US20140031544 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 01/30/2014 | US20140031391 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use |
| 01/30/2014 | US20140031378 Insecticidal spironindane derivatives |
| 01/30/2014 | US20140031374 Triazole derivatives as wnt signaling pathway inhibitors |
| 01/30/2014 | US20140031369 N-cyclopropyl-n-piperidinyl-amide derivatives, pharmaceutical compositions containing them and uses thereof |
| 01/30/2014 | US20140031368 Selective hdac inhibitors |
| 01/30/2014 | US20140031361 Inhibitors of protein kinases |
| 01/30/2014 | US20140031360 Bicyclic compounds as pim inhibitors |
| 01/30/2014 | US20140031358 Quinazolinediones and their use |
| 01/30/2014 | US20140031355 Heterocyclic compounds and their uses |